IPSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.8 EUR | -0.49% |
|
+0.75% | +11.96% |
| 14/05 | Ipsen: share price up, analyst raises target | CF |
| 14/05 | IPSEN : Barclays raises its target price | CF |
Presenter SpeechMarc De Garidel (Executives)[Presentation]
So good...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
Pharmaceuticals
Calendar
28/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.8
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.96% | 1.09TCr | |
| +32.09% | 69TCr | |
| +29.39% | 59TCr | |
| -1.34% | 37TCr | |
| +20.34% | 33TCr | |
| +7.39% | 29TCr | |
| +14.25% | 24TCr | |
| -3.03% | 21TCr | |
| +10.02% | 21TCr | |
| +8.49% | 17TCr |
- Stock Market
- Equities
- IPN Stock
- News Ipsen
- Transcript : Ipsen S.A., 2014 Earnings Call, Mar 03, 2015
